Global Business Innovation Programme in Boston and New York - FemTech
Companies in the FemTech sector are invited to join a market visit to New York and Boston, including the Femtech and Consumer Innovation Summit.
Opportunity Details
When
Registration Opens
21/11/2023
Registration Closes
26/01/2024
Award
Innovate UK will fund and organise flights, accommodation, in-market travel, and conference fees for successful applicants. Innovate UK will also pay for any reasonable adjustments throughout the initiative. One representative from each company will be funded.
Organisation
Innovate UK
Note: This opportunity is fully funded support and not monetary funding.
We are currently accepting applications for up to 15 companies in the FemTech sector to join our programme supported by various research centres and businesses in New York / Boston – USA. The Programme is focused on helping your business to maximise the opportunities in the USA and will include a visit to the Femtech and Consumer Innovation Summit in New York that connects innovative businesses to investors and industry experts.
Participants will be provided with pre-visit support from an Innovate UK EDGE Innovation and Growth Specialist and also given the opportunity to work with US investors for the investor pitch preparation. The aim is to foster and support collaborative research and development through UK and US partnerships. The innovation visit will include a visit to the Femtech and Consumer Innovation Summit in New York, USA, from 5-6 June 2024
We welcome applications from businesses developing innovative technologies that improve healthcare for female-specific health conditions such as fertility & birth control, menstruation and period care products, menopause, chronic conditions and hormonal disorders, pelvic health, pregnancy and post-pregnancy, breast feeding, and sexual wellness.
Areas of focus include:
- Solutions for Female Specific Health Conditions
- Fertility & Birth Control
- Menstruation and Period Care Products
- General Health Conditions Affecting Women Disproportionately
- Osteoporosis, Breast Cancer, Autoimmune Conditions
- Stroke, Mental Health, Cardiovascular Disease
- Innovations in Healthcare for Women
- Research and Development in FemTech
- Collaborative Partnerships for Women’s Health
-
A GBIP has three stages:
Prepare for the market
Preparing for the market includes the cohort being briefed by sector and market experts on, for example, cultural aspects of conducting business in that country. Delegates receive help to find business partners and arrange meetings and are advised on best practice including the management and protection of their intellectual property.
Visiting the market
Visiting the market provides opportunities to attend pre-arranged meetings and activities in order to better understand and maximise the opportunities that the visit presents.
Exploiting the opportunity
Exploiting the opportunity is arguably the most important aspect of the programme. To maximise the opportunity, participating companies are given bespoke one-to-one support from an Innovate UK EDGE innovation and growth specialist to help develop and implement an action plan.
The Global Business Innovation Programme operates on a competitive basis and businesses selected are required to participate in all three stages (some or all of which may be online).
-
To apply for this
initiative, you must be a UK based company, with fewer than 500 employees, and have a focus on FemTech.On acceptance to the Programme a commitment fee of £500 will be obtained from each delegate, which will be refunded on completion of the full activities and agreed action plan. Non-completion after formal acceptance may result in forfeiting some or all the commitment fee.
-
Boston is one of the leading life science hubs in the world, and has established itself as an early industry-leader in FemTech, with an ecosystem that ranges from well-established start-ups to global companies that are revolutionizing women’s healthcare access. There are also world-renowned academic and medical institutions in Boston, including Mass General Brigham and the Dana Farber Cancer Institute, that have been conducting significant research on women-specific issues. In the past, many academic institutions have been eager to collaborate with UK businesses in the health and the life sciences ecosystem, and we expect ample interest in engaging with UK businesses in the FemTech sector.
New York has established itself as a leader in the US FemTech ecosystem, by fostering a significant amount of start-ups and reproductive care initiatives. New York has also held several FemTech summits and conferences, with the upcoming 2024 FemTech Consumer and Innovation Summit being held in the city. There is a higher concentration of women-led Venture Capitalist firms, and women in leadership roles in investment, that we expect to be intrigued by the UK FemTech delegation that will be visiting.
-
The innovation visit will include a visit to the Femtech and Consumer Innovation Summit in New York, USA, from 5-6 June 2024. The summit will bring together leading investors, consumer pharmaceutical companies, femtech and consumer health startups, CPGs, FMCGs, marketing brands, digital giants, retailers, lifestyle, and wellness brands, and supply chain and manufacturing companies.
-
Register for the applicant briefing event on 12th December 2023 here.
Itinerary:
14th March 2024 Pre Visit Briefings.
17th & 18th April 2024 DBT US Investor forum – Pitch Practice
3rd – 7th June 2024 Innovation visit (Boston – New York).
8th June 2024 Arrive back in the UK.
For more information, assistance with your application or to discuss accessibility needs, please contact: Dr Dilruk Yahathugoda at dilruk.yahathugoda@innovateukedge.ukri.org